ARTICLE | Market Access
U.K. proposes model to value any antimicrobial as a subscription
Getting other countries to adopt similar strategies will be key to stimulating antibiotics development, says John Rex
July 20, 2023 12:45 AM UTC
U.K.’s NHS has proposed updating its landmark subscription-based pilot agreement for antibiotics from a product-by-product economic analysis to a points-based scoring system that will allow antimicrobial developers to understand how much the country will be willing to pay for their products, if at all, prior to regulatory approval — and regardless of usage.
Announced on July 11, the proposal comes a year after NHS England started paying for the antibiotics Zavicefta ceftazidime/avibactam from Pfizer Inc. (NYSE:PFE) and Fetcroja cefiderocol from Shionogi & Co. Ltd. (Tokyo:4507) in a pilot program of a subscription-based model...